# L_2012192EN.01001601.xml

| 20.7.2012 | EN | Official Journal of the European Union | L 192/16 |
| --- | --- | --- | --- |

20.7.2012

EN

Official Journal of the European Union

L 192/16

---

COMMISSION IMPLEMENTING DECISION

of 17 July 2012

amending Decision 2010/472/EU as regards animal health requirements relating to Simbu viruses and epizootic haemorrhagic disease

(notified under document C(2012) 4831)

(Text with EEA relevance)

(2012/411/EU)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in and imports into the Community of animals, semen, ova and embryos not subject to animal health requirements laid down in specific Community rules referred to in Annex A(I) to Directive 90/425/EEC (1), and in particular Article 17(2)(b), the first indent of Article 18(1), and the introductory phrase and point (b) of Article 19 thereof,

Whereas:

| (1) | Commission Decision 2010/472/EU of 26 August 2010 on imports of semen, ova and embryos of animals of the ovine and caprine species into the Union (2) sets out a list of third countries or parts thereof from which Member States are to authorise the importation into the Union of consignments of semen, ova and embryos of animals of the ovine and caprine species. It also lays down additional guarantees as regards specific animal diseases to be provided by certain third countries or parts thereof listed in Annexes I and III thereto and establishes the model health certificates for such imports in Part 2 of Annexes II and IV thereto. |
| --- | --- |

(1)

Commission Decision 2010/472/EU of 26 August 2010 on imports of semen, ova and embryos of animals of the ovine and caprine species into the Union (2) sets out a list of third countries or parts thereof from which Member States are to authorise the importation into the Union of consignments of semen, ova and embryos of animals of the ovine and caprine species. It also lays down additional guarantees as regards specific animal diseases to be provided by certain third countries or parts thereof listed in Annexes I and III thereto and establishes the model health certificates for such imports in Part 2 of Annexes II and IV thereto.

| (2) | The animal health requirements relating to bluetongue in the model health certificates set out in Part 2 of Annexes II and IV to Decision 2010/472/EU are based on the recommendations of Chapter 8.3 of the Terrestrial Animal Health Code of the World Organisation for animal Health (OIE) which deals with that disease. That Chapter recommends a whole range of risk mitigating measures aiming at either protecting the mammalian host from exposure to the infectious vector or at inactivating the virus by antibodies. |
| --- | --- |

(2)

The animal health requirements relating to bluetongue in the model health certificates set out in Part 2 of Annexes II and IV to Decision 2010/472/EU are based on the recommendations of Chapter 8.3 of the Terrestrial Animal Health Code of the World Organisation for animal Health (OIE) which deals with that disease. That Chapter recommends a whole range of risk mitigating measures aiming at either protecting the mammalian host from exposure to the infectious vector or at inactivating the virus by antibodies.

| (3) | In addition, the OIE has laid down a Chapter on Surveillance for arthropod vectors of animal diseases in the Terrestrial Animal Health Code. Those recommendations do not include the monitoring of ruminants for antibodies to Simbu viruses, such as the Akabane and Aino viruses of the Bunyaviridae family, which in the past was considered an economical method for determining the distribution of bluetongue competent vectors until more information on the spread of those diseases became available. |
| --- | --- |

(3)

In addition, the OIE has laid down a Chapter on Surveillance for arthropod vectors of animal diseases in the Terrestrial Animal Health Code. Those recommendations do not include the monitoring of ruminants for antibodies to Simbu viruses, such as the Akabane and Aino viruses of the Bunyaviridae family, which in the past was considered an economical method for determining the distribution of bluetongue competent vectors until more information on the spread of those diseases became available.

| (4) | Also, the OIE does not list Akabane and Aino diseases in the Terrestrial Animal Health Code. Consequently, the requirement for annual testing for those diseases to prove the absence of the vector should be deleted from Annexes I and III to Decision 2010/472/EU and from the model health certificates set out in Part 2 of Annexes II and IV thereto. |
| --- | --- |

(4)

Also, the OIE does not list Akabane and Aino diseases in the Terrestrial Animal Health Code. Consequently, the requirement for annual testing for those diseases to prove the absence of the vector should be deleted from Annexes I and III to Decision 2010/472/EU and from the model health certificates set out in Part 2 of Annexes II and IV thereto.

| (5) | In addition, the animal health requirements for epizootic haemorrhagic disease in the model health certificates in Part 2 of Annexes II and IV to Decision 2010/472/EU are not entirely consistent with the requirements laid down in Commission Implementing Decision 2011/630/EU of 20 September 2011 on imports into the Union of semen of domestic animals of the bovine species (3) and the recommendations of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE. Those model health certificates should therefore be amended to take account of the requirements laid down in Implementing Decision 2011/630/EU and the recommendations of that Manual. |
| --- | --- |

(5)

In addition, the animal health requirements for epizootic haemorrhagic disease in the model health certificates in Part 2 of Annexes II and IV to Decision 2010/472/EU are not entirely consistent with the requirements laid down in Commission Implementing Decision 2011/630/EU of 20 September 2011 on imports into the Union of semen of domestic animals of the bovine species (3) and the recommendations of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE. Those model health certificates should therefore be amended to take account of the requirements laid down in Implementing Decision 2011/630/EU and the recommendations of that Manual.

| (6) | The Annexes to Decision 2010/472/EU should therefore be amended accordingly. |
| --- | --- |

(6)

The Annexes to Decision 2010/472/EU should therefore be amended accordingly.

| (7) | To avoid any disruption of trade, the use of health certificates issued in accordance with Decision 2010/472/EU in its version prior to the amendments introduced by this Decision should be authorised during a transitional period subject to certain conditions. |
| --- | --- |

(7)

To avoid any disruption of trade, the use of health certificates issued in accordance with Decision 2010/472/EU in its version prior to the amendments introduced by this Decision should be authorised during a transitional period subject to certain conditions.

| (8) | The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health, |
| --- | --- |

(8)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

The Annexes to Decision 2010/472/EU are amended in accordance with the Annex to this Decision.

Article 2

For a transitional period until 30 June 2013, Member States shall authorise imports from third countries of consignments of:

| (a) | semen of animals of the ovine and caprine species which are accompanied by a health certificate issued not later than 31 May 2013 in accordance with the model health certificate set out in Section A of Part 2 of Annex II to Decision 2010/472/EU in its version prior to the amendments introduced by this Decision. |
| --- | --- |

(a)

semen of animals of the ovine and caprine species which are accompanied by a health certificate issued not later than 31 May 2013 in accordance with the model health certificate set out in Section A of Part 2 of Annex II to Decision 2010/472/EU in its version prior to the amendments introduced by this Decision.

| (b) | ova and embryos of animals of the ovine and caprine species accompanied by a health certificate issued not later than 31 May 2013 in accordance with the model health certificate set out in Part 2 of Annex IV to Decision 2010/472/EU in its version prior to the amendments introduced by this Decision. |
| --- | --- |

(b)

ova and embryos of animals of the ovine and caprine species accompanied by a health certificate issued not later than 31 May 2013 in accordance with the model health certificate set out in Part 2 of Annex IV to Decision 2010/472/EU in its version prior to the amendments introduced by this Decision.

Article 3

This Decision shall apply from 1 January 2013.

Article 4

This Decision is addressed to the Member States.

Done at Brussels, 17 July 2012.

For the Commission

John DALLI

Member of the Commission

---

(1)  
  OJ L 268, 14.9.1992, p. 54.

1

(2)  
  OJ L 228, 31.8.2010, p. 74.

2

(3)  
  OJ L 247, 24.9.2011, p. 32.

3

---

ANNEX

The Annexes to Decision 2010/472/EU are amended as follows:

| (1) | Annex I is replaced by the following:



  ‘ANNEX I

  List of third countries or parts thereof from which Member States are to authorise imports of consignments of semen of animals of the ovine and caprine species









  ISO Code | Name of the third country | Remarks |
| --- | --- | --- | --- |
| Description of the territory
  (if appropriate) | Additional guarantees |
| AU | Australia | | The additional guarantee as regards testing set out in point II.4.9.1 of the model health certificate set out in Section A of Part 2 of Annex II is compulsory. |
| CA | Canada | | The additional guarantee as regards testing set out in point II.4.9.1 of the model health certificate set out in Section A of Part 2 of Annex II is compulsory. |
| CH | Switzerland (*1) | | |
| CL | Chile | | |
| GL | Greenland | | |
| HR | Croatia | | |
| IS | Iceland | | |
| NZ | New Zealand | | |
| PM | Saint Pierre and Miquelon | | |
| US | United States | | The additional guarantee as regards testing set out in point II.4.9.1 of the model health certificate set out in Section A of Part 2 of Annex II is compulsory. |

(1)

Annex I is replaced by the following:

‘ANNEX I

List of third countries or parts thereof from which Member States are to authorise imports of consignments of semen of animals of the ovine and caprine species

ISO Code

Name of the third country

Remarks

Description of the territory

(if appropriate)

Additional guarantees

AU

Australia

The additional guarantee as regards testing set out in point II.4.9.1 of the model health certificate set out in Section A of Part 2 of Annex II is compulsory.

CA

Canada

The additional guarantee as regards testing set out in point II.4.9.1 of the model health certificate set out in Section A of Part 2 of Annex II is compulsory.

CH

Switzerland (*1)

CL

Chile

GL

Greenland

HR

Croatia

IS

Iceland

NZ

New Zealand

PM

Saint Pierre and Miquelon

US

United States

The additional guarantee as regards testing set out in point II.4.9.1 of the model health certificate set out in Section A of Part 2 of Annex II is compulsory.

| (2) | in Part 2 of Annex II, Section A is replaced by the following:

  ‘
  Section A

  Model 1 — Health certificate for semen dispatched from an approved semen collection centre of origin of the semen





  Text of image

  Part I: Details of dispatched consignment
  COUNTRY
  Veterinary certificate to EU
  I.1. Consignor
  Name
  Address
  Tel.
  I.2. Certificate reference No
  I.2.a.
  I.3. Central competent authority
  I.4. Local competent authority
  I.5. Consignee
  Name
  Address
  Postal code
  Tel.
  I.6. Person responsible for the load in EU
  Name
  Address
  Postal code
  Tel.
  I.7. Country of origin
  ISO code
  I.8. Region of origin
  Code
  I.9. Country of destination
  ISO code
  I.10. Region of destination
  Code
  I.11. Place of origin
  Name
  Approval number
  Address
  Name
  Approval number
  Address
  Name
  Approval number
  Address
  I.12. Place of destination
  Name
  Address
  Postal code
  I.13. Place of loading
  I.14. Date of departure
  I.15. Means of transport
  Aeroplane
  Ship
  Railway wagon
  Road vehicle
  Other
  Identification
  Documentary references
  I.16. Entry BIP in EU
  I.17.
  I.18. Description of commodity
  I.19. Commodity code (HS code)
  05 11 99 85
  I.20. Quantity
  I.21.
  I.22. Number of packages
  I.23. Seal/container No
  I.24.
  I.25. Commodities certified for:
  Artificial reproduction
  I.26. For transit through EU to third country
  Third country
  ISO code
  I.27. For import or admission into EU
  I.28. Identification of the commodities
  Species
  (scientific name)
  Breed
  Dondor identity
  Date of collection
  Approval number of the centre
  Quantity






  Text of image

  Part II: Certification
  COUNTRY
  Ovine and caprine semen — Section A
  II. Health information
  II.a. Certificate reference No
  II.b.
  I, the undersigned, official veterinarian, hereby certify that:
  II.1. The exporting country ...
  (name of exporting country) (2)
  II.1.1. has been free from rinderpest, peste des petits ruminants, sheep and goat pox, contagious caprine pleuropneumonia and Rift Valley fever during the 12 months immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against these diseases took place during that period;
  II.1.2. has been free from foot-and-mouth disease during the 12 months immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against this disease took place during that period.
  II.2. The semen collection centre described in Box I.11 and at which the semen to be exported was collected and stored:
  II.2.1. meets the conditions for the approval of semen collection centres laid down in Chapter I(I)(1) of Annex D to Directive 92/65/EEC;
  II.2.2. is operated and supervised in accordance with the conditions applicable to semen collection centres and storage centres laid down in Chapter I(II)(1) of Annex D to Directive 92/65/EEC.
  II.3. The ovine/caprine (1) animals standing at the semen collection centre:
  II.3.1. prior to their stay in the quarantine accommodation described in point II.3.3,
  (1)(4) either [II.3.1.1. originate from the territory described in Box I.8, which has been recognised as officially brucellosis (B. melitensis)-free,]
  (1)or [II.3.1.1. have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC,]
  (1)or [II.3.1.1. originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from clinical or any signs of this disease for the last 12 months, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than two years ago, and all ovine and caprine animals over six months of age have been subjected to at least two tests (3), carried out with negative results on samples taken on ... (date) and on ... (date) at least six months apart, the latter being within 30 days of entry into the quarantine accommodation,]
  and have not been kept previously in a holding of a lower status;
  II.3.1.2. have been kept continuously for at least 60 days on a holding where no case of contagious epididymitis (Brucella ovis) has been diagnosed in the last 12 months,
  (1) and [they are animals of the ovine species and have undergone during the 60 days prior to their stay in the quarantine accommodation described in point II.3.3 a complement fixation test, or any other test with an equivalent documented sensitivity and specificity, to detect contagious epididymitis with result of less than 50 ICFTU/ml;]
  II.3.1.3. to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in (a) to (d) prior to their stay in the quarantine accommodation described in point II.3.3:
  (a) contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides “large colony”), within the last six months;
  (b) paratuberculosis and caseous lymphadenitis, within the last 12 months;
  (c) pulmonary adenomatosis, within the last three years;
  (1) either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last three years;]
  (1) or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 months, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least six months apart;]
  II.3.2. have undergone the following tests carried out on a blood sample collected within the 28 days preceding the commencement of the period of quarantine specified in point II.3.3 for:






  Text of image

  COUNTRY
  Ovine and caprine semen — Section A
  II. Health information
  II.a. Certificate reference No
  II.b.
  brucellosis (B. melitensis), with negative results in each case in accordance with Annex C to Directive 91/68/EEC,
  contagious epididymitis (Brucella. ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity,
  border disease in accordance with point 1.4 (c) of Chapter II(II) of Annex D to Directive 92/65/EEC;
  II.3.3. have satisfied the quarantine isolation period of at least 28 days in a quarantine accommodation specifically approved for the purpose by the competent authority and during that period
  II.3.3.1. only animals of at least the same health status were present in the quarantine accommodation;
  II.3.3.2. the animals have undergone the following tests, carried out by the laboratory approved by the competent authority of the exporting country on samples taken not earlier than 21 days after the animals were admitted to the quarantine accommodation, for:
  brucellosis (B. melitensis) with negative results in accordance with Annex C to Directive 91/68/EEC,
  contagious epididymitis (Brucella ovis), in the case of sheep only, with negative results in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity,
  border disease in accordance with point 1.6 of Chapter II(II) of Annex D to Directive 92/65/EEC;
  II.3.4. have undergone at least once a year the routine tests with negative results for:
  brucellosis (B. melitensis) in accordance with Annex C to Directive 91/68/EEC,
  contagious epididymitis (Brucella ovis) in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity; in the case of sheep only,
  border disease in accordance with point 5(c) of Chapter II(II) of Annex D to Directive 92/65/EEC.
  II.4. The semen to be exported was obtained from donor rams/bucks (1) which:
  II.4.1. were admitted to the approved semen collection centre with the express permission of the centre veterinarian;
  II.4.2. show no clinical signs of disease on the day of admission to the approved semen collection centre and on the day the semen was collected;
  (1) either [II.4.3. have not been vaccinated against foot-and-mouth disease during the 12 months prior to collection of the semen;]
  (1) or [II.4.3. have been vaccinated against foot-and-mouth disease at least 30 days prior to the collection, and 5 % (with a minimum of five straws) of each collection have been submitted to a virus isolation test for foot-and-mouth disease with negative results;]
  II.4.4. have been kept at an approved semen collection centre for a continuous period of at least 30 days immediately prior to collection of the semen, in the case of collections of fresh semen;
  II.4.5. have not served naturally after their entry to the quarantine accommodation described in point II.3.3 and up to and including the day of semen collection;
  II.4.6. have been kept at the approved semen collection centres:
  II.4.6.1. which have been free from foot-and-mouth disease for at least three months prior to collection of the semen and 30 days after collection or, in the case of fresh semen, until the date of dispatch, and which are situated in the centre of an area of 10 kilometres radius in which there has been no case of foot-and-mouth disease for at least 30 days prior to collection of the semen;
  II.4.6.2. which have been free, during the period commencing 30 days prior to collection and ending 30 days after collection of the semen or, in the case of fresh semen, until the date of dispatch, from brucellosis (B. melitensis), contagious epididymitis (Brucella. ovis), anthrax and rabies;






  Text of image

  COUNTRY
  Ovine and caprine semen — Section A
  II. Health information
  II.a. Certificate reference No
  II.b.
  (1) either [II.4.7. have remained in the exporting country for at least the past six months prior to collection of the semen to be exported;]
  (1) or [II.4.7. during the past six months prior to collection of the semen they satisfied the animal health conditions applying to donors of the semen which is intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the semen from ... (2);]
  (1) either [II.4.8. were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the semen;]
  (1) or [II.4.8. were kept during a bluetongue virus seasonally free period in a seasonally free zone for at least 60 days prior to, and during collection of the semen;]
  (1) or [II.4.8. were kept in a vector-protected establishment for at least 60 days prior to, and during collection of the semen;]
  (1) or [II.4.8. were subjected to a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, with negative results, at least every 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen;]
  (1) or [II.4.8. were subjected to an agent identification test for bluetongue virus, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals with negative results on blood samples taken at commencement and final collection for this consignment of semen and at least every seven days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen;]
  II.4.9. were resident in the exporting country,
  (1)(5) either [II.4.9.1. which according to official findings is free from epizootic haemorrhagic disease (EHD);]
  (1) or [II.4.9.1. in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: ... and were subjected with negative results in each case to:
  (1) either [on two occasions not more than 12 months apart in a serological test (6) carried out in an approved laboratory on samples of blood taken prior to and not less than 21 days following collection for this consignment of semen.]
  (1) or [a serological test (6) for the detection of antibody to the EHDV group, carried out on samples taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen.]
  (1) or [an agent identification test (6) carried out in approved laboratories on blood samples collected at commencement and conclusion of, and at least every seven days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen.]]
  II.5. The semen to be exported:
  II.5.1. was collected after the date on which the semen collection centre was approved by the competent authority of the exporting country;
  II.5.2. was collected, processed, preserved, stored and transported in accordance with the requirements applicable to semen laid down in Chapter III(I) of Annex D to Directive 92/65/EEC;
  (1) either [II.5.3. meets the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001;]
  (1) or [II.5.3. meets the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and is destined for a Member State which benefits, for all or part of its territory, from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and the donor animals comply regarding scrapie with the guarantees provided for by the national scrapie control program referred to in those points and with the guarantees (7) requested by the Member State of destination;]
  II.5.4. was sent to the place of loading in a sealed container in accordance with the requirements for semen to be subject to trade laid down in point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in Box I.23.
  (1) either [II.6. No antibiotics were added to the semen.]






  Text of image

  COUNTRY
  Ovine and caprine semen — Section A
  II. Health information
  II.a. Certificate reference No
  II.b.
  (1) or [II.6. The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than (8):
  ... ]
  Notes
  Part I:
  Box I.6: Person responsible for the load in EU: this box is to be filled in only if it is a certificate for transit commodity
  Box I.11: Place of origin shall correspond to the approved semen collection centre in which the semen was collected and listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm
  Box I.22: number of packages shall correspond to the number of containers.
  Box I.23: identification of container and seal number shall be indicated.
  Box I.26: fill in according to whether it is a transit or an import certificate.
  Box I.27: fill in according to whether it is a transit or an import certificate.
  Box I.28: Species: select amongst “Ovis aries” or “Capra hircus” as appropriate.
  Donor identity shall correspond to the official identification of the animal.
  Date of collection shall be indicated in the following format: dd.mm.yyyy.
  Approval number of the centre shall correspond to the approval number of the semen collection centre indicated in Box I.11.
  Part II:
  (1) Delete as necessary.
  (2) Only third countries listed in Annex I to Decision 2010/472/EU.
  (3) Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.
  (4) Only for the territory appearing with the entry “V” in column 6 of Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1).
  (5) See remarks for exporting country concerned in Annex I to Decision 2010/472/EU.
  (6) Standards for EHD virus diagnostic tests are described in Chapter 2.1.3 of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.
  (7) Additional guarantees as laid down in Article 2 of Regulation (EC) No 546/2006 (OJ L 94, 1.4.2006, p. 28).
  (8) Insert names and concentrations.
  Official veterinarian (*)
  Name (in capital letters):
  Qualification and title:
  Date:
  Signature:
  Stamp:
  (*) The signature and the stamp must be in a different colour to that of the printing.’ |
| --- | --- |

(2)

in Part 2 of Annex II, Section A is replaced by the following:

‘
  Section A

Section A

Model 1 — Health certificate for semen dispatched from an approved semen collection centre of origin of the semen

Image 1

Part I: Details of dispatched consignment

COUNTRY

Veterinary certificate to EU

I.1. Consignor

Name

Address

Tel.

I.2. Certificate reference No

I.2.a.

I.3. Central competent authority

I.4. Local competent authority

I.5. Consignee

Name

Address

Postal code

Tel.

I.6. Person responsible for the load in EU

Name

Address

Postal code

Tel.

I.7. Country of origin

ISO code

I.8. Region of origin

Code

I.9. Country of destination

ISO code

I.10. Region of destination

Code

I.11. Place of origin

Name

Approval number

Address

Name

Approval number

Address

Name

Approval number

Address

I.12. Place of destination

Name

Address

Postal code

I.13. Place of loading

I.14. Date of departure

I.15. Means of transport

Aeroplane

Ship

Railway wagon

Road vehicle

Other

Identification

Documentary references

I.16. Entry BIP in EU

I.17.

I.18. Description of commodity

I.19. Commodity code (HS code)

05 11 99 85

I.20. Quantity

I.21.

I.22. Number of packages

I.23. Seal/container No

I.24.

I.25. Commodities certified for:

Artificial reproduction

I.26. For transit through EU to third country

Third country

ISO code

I.27. For import or admission into EU

I.28. Identification of the commodities

Species

(scientific name)

Breed

Dondor identity

Date of collection

Approval number of the centre

Quantity

Image 2

Part II: Certification

COUNTRY

Ovine and caprine semen — Section A

II. Health information

II.a. Certificate reference No

II.b.

I, the undersigned, official veterinarian, hereby certify that:

II.1. The exporting country ...

(name of exporting country) (2)

II.1.1. has been free from rinderpest, peste des petits ruminants, sheep and goat pox, contagious caprine pleuropneumonia and Rift Valley fever during the 12 months immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against these diseases took place during that period;

II.1.2. has been free from foot-and-mouth disease during the 12 months immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against this disease took place during that period.

II.2. The semen collection centre described in Box I.11 and at which the semen to be exported was collected and stored:

II.2.1. meets the conditions for the approval of semen collection centres laid down in Chapter I(I)(1) of Annex D to Directive 92/65/EEC;

II.2.2. is operated and supervised in accordance with the conditions applicable to semen collection centres and storage centres laid down in Chapter I(II)(1) of Annex D to Directive 92/65/EEC.

II.3. The ovine/caprine (1) animals standing at the semen collection centre:

II.3.1. prior to their stay in the quarantine accommodation described in point II.3.3,

(1)(4) either [II.3.1.1. originate from the territory described in Box I.8, which has been recognised as officially brucellosis (B. melitensis)-free,]

(1)or [II.3.1.1. have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC,]

(1)or [II.3.1.1. originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from clinical or any signs of this disease for the last 12 months, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than two years ago, and all ovine and caprine animals over six months of age have been subjected to at least two tests (3), carried out with negative results on samples taken on ... (date) and on ... (date) at least six months apart, the latter being within 30 days of entry into the quarantine accommodation,]

and have not been kept previously in a holding of a lower status;

II.3.1.2. have been kept continuously for at least 60 days on a holding where no case of contagious epididymitis (Brucella ovis) has been diagnosed in the last 12 months,

(1) and [they are animals of the ovine species and have undergone during the 60 days prior to their stay in the quarantine accommodation described in point II.3.3 a complement fixation test, or any other test with an equivalent documented sensitivity and specificity, to detect contagious epididymitis with result of less than 50 ICFTU/ml;]

II.3.1.3. to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in (a) to (d) prior to their stay in the quarantine accommodation described in point II.3.3:

(a) contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides “large colony”), within the last six months;

(b) paratuberculosis and caseous lymphadenitis, within the last 12 months;

(c) pulmonary adenomatosis, within the last three years;

(1) either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last three years;]

(1) or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 months, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least six months apart;]

II.3.2. have undergone the following tests carried out on a blood sample collected within the 28 days preceding the commencement of the period of quarantine specified in point II.3.3 for:

Image 3

COUNTRY

Ovine and caprine semen — Section A

II. Health information

II.a. Certificate reference No

II.b.

brucellosis (B. melitensis), with negative results in each case in accordance with Annex C to Directive 91/68/EEC,

contagious epididymitis (Brucella. ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity,

border disease in accordance with point 1.4 (c) of Chapter II(II) of Annex D to Directive 92/65/EEC;

II.3.3. have satisfied the quarantine isolation period of at least 28 days in a quarantine accommodation specifically approved for the purpose by the competent authority and during that period

II.3.3.1. only animals of at least the same health status were present in the quarantine accommodation;

II.3.3.2. the animals have undergone the following tests, carried out by the laboratory approved by the competent authority of the exporting country on samples taken not earlier than 21 days after the animals were admitted to the quarantine accommodation, for:

brucellosis (B. melitensis) with negative results in accordance with Annex C to Directive 91/68/EEC,

contagious epididymitis (Brucella ovis), in the case of sheep only, with negative results in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity,

border disease in accordance with point 1.6 of Chapter II(II) of Annex D to Directive 92/65/EEC;

II.3.4. have undergone at least once a year the routine tests with negative results for:

brucellosis (B. melitensis) in accordance with Annex C to Directive 91/68/EEC,

contagious epididymitis (Brucella ovis) in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity; in the case of sheep only,

border disease in accordance with point 5(c) of Chapter II(II) of Annex D to Directive 92/65/EEC.

II.4. The semen to be exported was obtained from donor rams/bucks (1) which:

II.4.1. were admitted to the approved semen collection centre with the express permission of the centre veterinarian;

II.4.2. show no clinical signs of disease on the day of admission to the approved semen collection centre and on the day the semen was collected;

(1) either [II.4.3. have not been vaccinated against foot-and-mouth disease during the 12 months prior to collection of the semen;]

(1) or [II.4.3. have been vaccinated against foot-and-mouth disease at least 30 days prior to the collection, and 5 % (with a minimum of five straws) of each collection have been submitted to a virus isolation test for foot-and-mouth disease with negative results;]

II.4.4. have been kept at an approved semen collection centre for a continuous period of at least 30 days immediately prior to collection of the semen, in the case of collections of fresh semen;

II.4.5. have not served naturally after their entry to the quarantine accommodation described in point II.3.3 and up to and including the day of semen collection;

II.4.6. have been kept at the approved semen collection centres:

II.4.6.1. which have been free from foot-and-mouth disease for at least three months prior to collection of the semen and 30 days after collection or, in the case of fresh semen, until the date of dispatch, and which are situated in the centre of an area of 10 kilometres radius in which there has been no case of foot-and-mouth disease for at least 30 days prior to collection of the semen;

II.4.6.2. which have been free, during the period commencing 30 days prior to collection and ending 30 days after collection of the semen or, in the case of fresh semen, until the date of dispatch, from brucellosis (B. melitensis), contagious epididymitis (Brucella. ovis), anthrax and rabies;

Image 4

COUNTRY

Ovine and caprine semen — Section A

II. Health information

II.a. Certificate reference No

II.b.

(1) either [II.4.7. have remained in the exporting country for at least the past six months prior to collection of the semen to be exported;]

(1) or [II.4.7. during the past six months prior to collection of the semen they satisfied the animal health conditions applying to donors of the semen which is intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the semen from ... (2);]

(1) either [II.4.8. were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the semen;]

(1) or [II.4.8. were kept during a bluetongue virus seasonally free period in a seasonally free zone for at least 60 days prior to, and during collection of the semen;]

(1) or [II.4.8. were kept in a vector-protected establishment for at least 60 days prior to, and during collection of the semen;]

(1) or [II.4.8. were subjected to a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, with negative results, at least every 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen;]

(1) or [II.4.8. were subjected to an agent identification test for bluetongue virus, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals with negative results on blood samples taken at commencement and final collection for this consignment of semen and at least every seven days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen;]

II.4.9. were resident in the exporting country,

(1)(5) either [II.4.9.1. which according to official findings is free from epizootic haemorrhagic disease (EHD);]

(1) or [II.4.9.1. in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: ... and were subjected with negative results in each case to:

(1) either [on two occasions not more than 12 months apart in a serological test (6) carried out in an approved laboratory on samples of blood taken prior to and not less than 21 days following collection for this consignment of semen.]

(1) or [a serological test (6) for the detection of antibody to the EHDV group, carried out on samples taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen.]

(1) or [an agent identification test (6) carried out in approved laboratories on blood samples collected at commencement and conclusion of, and at least every seven days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen.]]

II.5. The semen to be exported:

II.5.1. was collected after the date on which the semen collection centre was approved by the competent authority of the exporting country;

II.5.2. was collected, processed, preserved, stored and transported in accordance with the requirements applicable to semen laid down in Chapter III(I) of Annex D to Directive 92/65/EEC;

(1) either [II.5.3. meets the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001;]

(1) or [II.5.3. meets the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and is destined for a Member State which benefits, for all or part of its territory, from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and the donor animals comply regarding scrapie with the guarantees provided for by the national scrapie control program referred to in those points and with the guarantees (7) requested by the Member State of destination;]

II.5.4. was sent to the place of loading in a sealed container in accordance with the requirements for semen to be subject to trade laid down in point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in Box I.23.

(1) either [II.6. No antibiotics were added to the semen.]

Image 5

COUNTRY

Ovine and caprine semen — Section A

II. Health information

II.a. Certificate reference No

II.b.

(1) or [II.6. The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than (8):

... ]

Notes

Part I:

Box I.6: Person responsible for the load in EU: this box is to be filled in only if it is a certificate for transit commodity

Box I.11: Place of origin shall correspond to the approved semen collection centre in which the semen was collected and listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm

Box I.22: number of packages shall correspond to the number of containers.

Box I.23: identification of container and seal number shall be indicated.

Box I.26: fill in according to whether it is a transit or an import certificate.

Box I.27: fill in according to whether it is a transit or an import certificate.

Box I.28: Species: select amongst “Ovis aries” or “Capra hircus” as appropriate.

Donor identity shall correspond to the official identification of the animal.

Date of collection shall be indicated in the following format: dd.mm.yyyy.

Approval number of the centre shall correspond to the approval number of the semen collection centre indicated in Box I.11.

Part II:

(1) Delete as necessary.

(2) Only third countries listed in Annex I to Decision 2010/472/EU.

(3) Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.

(4) Only for the territory appearing with the entry “V” in column 6 of Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1).

(5) See remarks for exporting country concerned in Annex I to Decision 2010/472/EU.

(6) Standards for EHD virus diagnostic tests are described in Chapter 2.1.3 of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.

(7) Additional guarantees as laid down in Article 2 of Regulation (EC) No 546/2006 (OJ L 94, 1.4.2006, p. 28).

(8) Insert names and concentrations.

Official veterinarian (*)

Name (in capital letters):

Qualification and title:

Date:

Signature:

Stamp:

(*) The signature and the stamp must be in a different colour to that of the printing.’

| (3) | Annex III is replaced by the following:



  ‘ANNEX III

  List of third countries or parts thereof from which Member States are to authorise imports of consignments of ova and embryos of animals of the ovine and caprine species









  ISO Code | Name of the third country | Remarks |
| --- | --- | --- | --- |
| Description of the territory

  (if appropriate) | Additional guarantees |
| AU | Australia | | The additional guarantee as regards testing set out in point II.2.6.1 of the model health certificate set out in Part 2 of Annex IV is compulsory. |
| CA | Canada | | The additional guarantee as regards testing set out in point II.2.6.1 of the model health certificate set out in Part 2 of Annex IV is compulsory. |
| CH | Switzerland (*2) | | |
| CL | Chile | | |
| GL | Greenland | | |
| HR | Croatia | | |
| IS | Iceland | | |
| NZ | New Zealand | | |
| PM | Saint Pierre and Miquelon | | |
| US | United States | | The additional guarantee as regards testing set out in point II.2.6.1 of the model health certificate set out in Part 2 of Annex IV is compulsory. |

(3)

Annex III is replaced by the following:

‘ANNEX III

List of third countries or parts thereof from which Member States are to authorise imports of consignments of ova and embryos of animals of the ovine and caprine species

ISO Code

Name of the third country

Remarks

Description of the territory

(if appropriate)

Additional guarantees

AU

Australia

The additional guarantee as regards testing set out in point II.2.6.1 of the model health certificate set out in Part 2 of Annex IV is compulsory.

CA

Canada

The additional guarantee as regards testing set out in point II.2.6.1 of the model health certificate set out in Part 2 of Annex IV is compulsory.

CH

Switzerland (*2)

CL

Chile

GL

Greenland

HR

Croatia

IS

Iceland

NZ

New Zealand

PM

Saint Pierre and Miquelon

US

United States

The additional guarantee as regards testing set out in point II.2.6.1 of the model health certificate set out in Part 2 of Annex IV is compulsory.

| (4) | Part 2 of Annex IV is replaced by the following:

  ‘PART 2

  Model health certificate for imports of consignments of ova and embryos of animals of the ovine and caprine species






  Text of image

  Part I: Details of dispatched consignment
  COUNTRY
  Veterinary certificate to EU
  I.1. Consignor
  Name
  Address
  Tel.
  I.2. Certificate reference No
  I.2.a.
  I.3. Central competent authority
  I.4. Local competent authority
  I.5. Consignee
  Name
  Address
  Postal code
  Tel.
  I.6. Person responsible for the load in EU
  Name
  Address
  Postal code
  Tel.
  I.7. Country of origin
  ISO code
  I.8. Region of origin
  Code
  I.9. Country of destination
  ISO code
  I.10. Region of destination
  Code
  I.11. Place of origin
  Name
  Approval number
  Address
  Name
  Approval number
  Address
  Name
  Approval number
  Address
  I.12. Place of destination
  Name
  Address
  Postal code
  I.13. Place of loading
  I.14. Date of departure
  I.15. Means of transport
  Aeroplane
  Ship
  Railway wagon
  Road vehicle
  Other
  Identification
  Documentary references
  I.16. Entry BIP in EU
  I.17.
  I.18. Description of commodity
  I.19. Commodity code (HS code)
  05 11 99 85
  I.20. Quantity
  I.21.
  I.22. Number of packages
  I.23. Seal/container No
  I.24.
  I.25. Commodities certified for:
  Artificial reproduction
  I.26. For transit through EU to third country
  Third country
  ISO code
  I.27. For import or admission into EU
  I.28. Identification of the commodities
  Species
  (scientific name)
  Breed
  Category
  Donor identity
  Date of collection
  Date of freezing
  Approval number of the team
  Quantity






  Text of image

  Part II: Certification
  COUNTRY
  Ovine and caprine ova/embryos
  II. Health information
  II.a. Certificate reference No
  II.b.
  I, the undersigned, official veterinarian, hereby certify that:
  II.1. The exporting country ...
  (name of exporting country) (2)
  II.1.1. has been free from rinderpest, peste des petits ruminants, sheep and goat pox, contagious caprine pleuropneumonia, and Rift Valley fever during the 12 months immediately prior to collection of the ova/embryos (1) to be exported and until their date of dispatch to the Union and no vaccination against these diseases took place during that period;
  (1) either [II.1.2. has been free from foot-and-mouth disease during the 12 months immediately prior to collection of the ova/embryos (1) and did not carry out vaccination against foot-and-mouth disease during that period;]
  (1) or [II.1.2. has not been free from foot-and-mouth disease during the 12 months immediately prior to collection of the ova/embryos (1) and/or carried out vaccination against foot-and-mouth disease during that period and the donor females come from holdings on which no animal was vaccinated against foot-and-mouth disease during 30 days prior to collection and no animal of susceptible species showed clinical signs of foot-and-mouth disease during the 30 days prior to, and at least 30 days after, the ova/embryos (1) were collected and the ova/embryos (1) were not subjected to penetration of zona pellucida;]
  II.2. The ova/embryos (1) to be exported:
  II.2.1. were collected/produced (1) and processed on premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis, Rift Valley fever in the 30 days immediately prior to their collection;
  II.2.2. were stored at all times on approved premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever from the time of their collection until 30 days thereafter;
  II.2.3. were collected/produced (1) by the team described in Box I.11, which has been approved and supervised in accordance with the conditions for the approval and supervision of embryo collection teams and embryo production teams laid down in Chapter I(III) of Annex D to Directive 92/65/EEC;
  II.2.4. meet the conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;
  II.2.5. come from the donor females of ovine/caprine (1) species which:
  (1) either [II.2.5.1. were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during collection of the ova/embryos (1);]
  (1) or [II.2.5.1. were kept during a bluetongue virus seasonally free period in a seasonally free zone;]
  (1) or [II.2.5.1. were kept protected from the vector for at least 60 days prior to, and during the collection of the ova/embryos (1);]
  (1) or [II.2.5.1. underwent a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection of the ova/embryos (1) and giving negative results;]
  (1) or [II.2.5.1. underwent an agent identification test for bluetongue virus, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of the ova/embryos (1) collection or the day of slaughtering and giving negative results;]
  II.2.5.2. to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in (a) to (d) prior to collection of the ova/embryos (1) to be exported:
  (a) contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides “large colony”), within the last six months;
  (b) paratuberculosis and caseous lymphadenitis, within the last 12 months;
  (c) pulmonary adenomatosis, within the last three years;
  (1) either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last three years;]
  (1) or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 months, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least six months apart;]






  Text of image

  COUNTRY
  Ovine and caprine ova/embryos
  II. Health information
  II.a. Certificate reference No
  II.b.
  II.2.5.3. showed no clinical signs of disease on the day of the ova/embryos (1) collection;
  (1)(4) either [II.2.5.4 originate from the region described in Box I.8., which has been recognised as officially brucellosis (B. melitensis)-free, and]
  (1) or [II.2.5.4. have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC, and]
  (1) or [II.2.5.4. originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from any clinical or any signs of this disease for the last 12 months, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than two years ago, and all ovine and caprine animals over six months of age have been subjected to at least two tests (3) , carried out with negative results on samples taken on ... (date) and on ... (date) at least six months apart, the latter being within 30 days prior to collection of the ova/embryos (1),]
  and have not been kept previously in a holding of a lower status;
  (1) either [II.2.5.5. have remained in the exporting country for at least the past six months prior to collection of the ova/embryos (1) to be exported;]
  (1) or [II.2.5.5 during the past six months prior to collection of the ova/embryos (1) they satisfied the animal health conditions applying to donors of the ova/embryos (1) which are intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the ova/embryos (1) from ... (2);]
  [II.2.6. were collected/produced (1) in the exporting country,
  (1) either [II.2.6.1. which according to official findings is free from epizootic haemorrhagic disease (EHD);]
  (1)(5) or [II.2.6.1. in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: ... and were subjected with negative results in each case to:
  (1) either [on two occasions not more than 12 months apart in a serological test (6) carried out in an approved laboratory on samples of blood taken prior to and not less than 21 days following collection for this consignment of ova/embryos (1);]
  (1) or [a serological test (6) for the detection of antibody to the EHDV group, carried out on samples taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of ova/embryos (1);]
  (1) or [an agent identification test (6) carried out in approved laboratories on blood samples collected at commencement and conclusion of, and at least every seven days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of ova/embryos (1);]]
  (1) either [II.2.8. meet the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001;]
  (1) or [II.2.8. meet the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and are destined for a Member State which benefits, for all or part of its territory, from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and the donor animals comply regarding scrapie with the guarantees provided for by the national scrapie control program referred to in that point and with the guarantees (7) requested by the Member State of destination;]
  II.2.9. were collected/produced (1) after the date on which the embryo collection team was approved by the competent authority of the exporting country;
  II.2.10. were processed and stored under approved conditions for at least 30 days immediately after their collection/production (1) and transported under conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;
  II.2.11. were sent to the place of loading in a sealed container in accordance with the requirements for the transport of embryos laid down in point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the number detailed in Box I.23;
  (9) II.2.12. were conceived by artificial insemination/as a result of in vitro fertilisation (1) using semen coming from semen collection centres.
  (1) either [II.2.12.1. approved in accordance with Article 11(2) of Directive 92/65/EEC and located in a Member State of the European Union; and the semen complies with the requirements of Directive 92/65/EEC.]
  (1) or [II.2.12.1. approved in accordance with Article 17(3)(b) of Directive 92/65/EEC and located in a third country or part thereof listed in Annex I to Decision 2010/472/EU, and the semen complies with the requirements set out in Part 2 of Annex II to that Decision.]






  Text of image

  COUNTRY
  Ovine and caprine ova/embryos
  II. Health information
  II.a. Certificate reference No
  II.b.
  Notes
  Part I:
  Box I.6: Person responsible for the load in EU: this box is to be filled in only if it is a certificate for transit commodity.
  Box I.11: Place of origin shall correspond to the approved embryo collection team or embryo production team by which the ova/embryos were collected/produced, processed and stored; and listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm
  Box I.22: number of packages shall correspond to the number of containers.
  Box I.23: identification of container and seal number shall be indicated.
  Box I.26: fill in according to whether it is a transit or an import certificate.
  Box I.27: fill in according to whether it is a transit or an import certificate.
  Box I.28: Species: select amongst “Ovis aries” or “Capra hircus” as appropriate.
  Category: specify if in vivo derived embryos, in vivo derived ova, in vitro produced embryos or micromanipulated embryos.
  Donor identity shall correspond to the official identification of the animal.
  Date of collection shall be indicated for in vivo derived embryos and in the following format: dd.mm.yyyy.
  Date of freezing shall be indicated in the following format: dd.mm.yyyy.
  Approval number of the team: shall correspond to the approved embryo collection team or embryo production team by which the ova/embryos were collected/produced, processed and stored; and listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm
  Part II:
  (1) Delete as appropriate.
  (2) Only third countries or parts thereof listed in Annex I to Decision 2010/472/EU.
  (3) Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.
  (4) Only for the territory appearing with the entry “V” in column 6 of Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010).
  (5) See remarks for exporting country or part thereof concerned in Annex III to Decision 2010/472/EU.
  (6) Standards for EHD virus diagnostic tests are described in Chapter 2.1.3 of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.
  (7) Additional guarantees as laid down in Article 2 of Regulation (EC) No 546/2006 (OJ L 94, 1.4.2006, p. 28).
  (8) Only approved semen collection centres listed in accordance with Article 11(4) and Article 17(3)(b) of Directive 92/65/EEC on the Commission websites:
  http://ec.europa.eu/food/animal/approved_establishments/establishments_vet_field_en.htm;
  http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm
  (9) Does not apply to ova.
  Official veterinarian (*)
  Name (in capital letters):
  Qualification and title:
  Date:
  Signature:
  Stamp:
  (*) The signature and the stamp must be in a different colour to that of the printing.’ |
| --- | --- |

(4)

Part 2 of Annex IV is replaced by the following:

‘PART 2

Model health certificate for imports of consignments of ova and embryos of animals of the ovine and caprine species

Model health certificate for imports of consignments of ova and embryos of animals of the ovine and caprine species

Image 6

Part I: Details of dispatched consignment

COUNTRY

Veterinary certificate to EU

I.1. Consignor

Name

Address

Tel.

I.2. Certificate reference No

I.2.a.

I.3. Central competent authority

I.4. Local competent authority

I.5. Consignee

Name

Address

Postal code

Tel.

I.6. Person responsible for the load in EU

Name

Address

Postal code

Tel.

I.7. Country of origin

ISO code

I.8. Region of origin

Code

I.9. Country of destination

ISO code

I.10. Region of destination

Code

I.11. Place of origin

Name

Approval number

Address

Name

Approval number

Address

Name

Approval number

Address

I.12. Place of destination

Name

Address

Postal code

I.13. Place of loading

I.14. Date of departure

I.15. Means of transport

Aeroplane

Ship

Railway wagon

Road vehicle

Other

Identification

Documentary references

I.16. Entry BIP in EU

I.17.

I.18. Description of commodity

I.19. Commodity code (HS code)

05 11 99 85

I.20. Quantity

I.21.

I.22. Number of packages

I.23. Seal/container No

I.24.

I.25. Commodities certified for:

Artificial reproduction

I.26. For transit through EU to third country

Third country

ISO code

I.27. For import or admission into EU

I.28. Identification of the commodities

Species

(scientific name)

Breed

Category

Donor identity

Date of collection

Date of freezing

Approval number of the team

Quantity

Image 7

Part II: Certification

COUNTRY

Ovine and caprine ova/embryos

II. Health information

II.a. Certificate reference No

II.b.

I, the undersigned, official veterinarian, hereby certify that:

II.1. The exporting country ...

(name of exporting country) (2)

II.1.1. has been free from rinderpest, peste des petits ruminants, sheep and goat pox, contagious caprine pleuropneumonia, and Rift Valley fever during the 12 months immediately prior to collection of the ova/embryos (1) to be exported and until their date of dispatch to the Union and no vaccination against these diseases took place during that period;

(1) either [II.1.2. has been free from foot-and-mouth disease during the 12 months immediately prior to collection of the ova/embryos (1) and did not carry out vaccination against foot-and-mouth disease during that period;]

(1) or [II.1.2. has not been free from foot-and-mouth disease during the 12 months immediately prior to collection of the ova/embryos (1) and/or carried out vaccination against foot-and-mouth disease during that period and the donor females come from holdings on which no animal was vaccinated against foot-and-mouth disease during 30 days prior to collection and no animal of susceptible species showed clinical signs of foot-and-mouth disease during the 30 days prior to, and at least 30 days after, the ova/embryos (1) were collected and the ova/embryos (1) were not subjected to penetration of zona pellucida;]

II.2. The ova/embryos (1) to be exported:

II.2.1. were collected/produced (1) and processed on premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis, Rift Valley fever in the 30 days immediately prior to their collection;

II.2.2. were stored at all times on approved premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever from the time of their collection until 30 days thereafter;

II.2.3. were collected/produced (1) by the team described in Box I.11, which has been approved and supervised in accordance with the conditions for the approval and supervision of embryo collection teams and embryo production teams laid down in Chapter I(III) of Annex D to Directive 92/65/EEC;

II.2.4. meet the conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;

II.2.5. come from the donor females of ovine/caprine (1) species which:

(1) either [II.2.5.1. were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during collection of the ova/embryos (1);]

(1) or [II.2.5.1. were kept during a bluetongue virus seasonally free period in a seasonally free zone;]

(1) or [II.2.5.1. were kept protected from the vector for at least 60 days prior to, and during the collection of the ova/embryos (1);]

(1) or [II.2.5.1. underwent a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection of the ova/embryos (1) and giving negative results;]

(1) or [II.2.5.1. underwent an agent identification test for bluetongue virus, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of the ova/embryos (1) collection or the day of slaughtering and giving negative results;]

II.2.5.2. to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in (a) to (d) prior to collection of the ova/embryos (1) to be exported:

(a) contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides “large colony”), within the last six months;

(b) paratuberculosis and caseous lymphadenitis, within the last 12 months;

(c) pulmonary adenomatosis, within the last three years;

(1) either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last three years;]

(1) or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 months, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least six months apart;]

Image 8

COUNTRY

Ovine and caprine ova/embryos

II. Health information

II.a. Certificate reference No

II.b.

II.2.5.3. showed no clinical signs of disease on the day of the ova/embryos (1) collection;

(1)(4) either [II.2.5.4 originate from the region described in Box I.8., which has been recognised as officially brucellosis (B. melitensis)-free, and]

(1) or [II.2.5.4. have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC, and]

(1) or [II.2.5.4. originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from any clinical or any signs of this disease for the last 12 months, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than two years ago, and all ovine and caprine animals over six months of age have been subjected to at least two tests (3) , carried out with negative results on samples taken on ... (date) and on ... (date) at least six months apart, the latter being within 30 days prior to collection of the ova/embryos (1),]

and have not been kept previously in a holding of a lower status;

(1) either [II.2.5.5. have remained in the exporting country for at least the past six months prior to collection of the ova/embryos (1) to be exported;]

(1) or [II.2.5.5 during the past six months prior to collection of the ova/embryos (1) they satisfied the animal health conditions applying to donors of the ova/embryos (1) which are intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the ova/embryos (1) from ... (2);]

[II.2.6. were collected/produced (1) in the exporting country,

(1) either [II.2.6.1. which according to official findings is free from epizootic haemorrhagic disease (EHD);]

(1)(5) or [II.2.6.1. in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: ... and were subjected with negative results in each case to:

(1) either [on two occasions not more than 12 months apart in a serological test (6) carried out in an approved laboratory on samples of blood taken prior to and not less than 21 days following collection for this consignment of ova/embryos (1);]

(1) or [a serological test (6) for the detection of antibody to the EHDV group, carried out on samples taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of ova/embryos (1);]

(1) or [an agent identification test (6) carried out in approved laboratories on blood samples collected at commencement and conclusion of, and at least every seven days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of ova/embryos (1);]]

(1) either [II.2.8. meet the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001;]

(1) or [II.2.8. meet the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and are destined for a Member State which benefits, for all or part of its territory, from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and the donor animals comply regarding scrapie with the guarantees provided for by the national scrapie control program referred to in that point and with the guarantees (7) requested by the Member State of destination;]

II.2.9. were collected/produced (1) after the date on which the embryo collection team was approved by the competent authority of the exporting country;

II.2.10. were processed and stored under approved conditions for at least 30 days immediately after their collection/production (1) and transported under conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;

II.2.11. were sent to the place of loading in a sealed container in accordance with the requirements for the transport of embryos laid down in point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the number detailed in Box I.23;

(9) II.2.12. were conceived by artificial insemination/as a result of in vitro fertilisation (1) using semen coming from semen collection centres.

(1) either [II.2.12.1. approved in accordance with Article 11(2) of Directive 92/65/EEC and located in a Member State of the European Union; and the semen complies with the requirements of Directive 92/65/EEC.]

(1) or [II.2.12.1. approved in accordance with Article 17(3)(b) of Directive 92/65/EEC and located in a third country or part thereof listed in Annex I to Decision 2010/472/EU, and the semen complies with the requirements set out in Part 2 of Annex II to that Decision.]

Image 9

COUNTRY

Ovine and caprine ova/embryos

II. Health information

II.a. Certificate reference No

II.b.

Notes

Part I:

Box I.6: Person responsible for the load in EU: this box is to be filled in only if it is a certificate for transit commodity.

Box I.11: Place of origin shall correspond to the approved embryo collection team or embryo production team by which the ova/embryos were collected/produced, processed and stored; and listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm

Box I.22: number of packages shall correspond to the number of containers.

Box I.23: identification of container and seal number shall be indicated.

Box I.26: fill in according to whether it is a transit or an import certificate.

Box I.27: fill in according to whether it is a transit or an import certificate.

Box I.28: Species: select amongst “Ovis aries” or “Capra hircus” as appropriate.

Category: specify if in vivo derived embryos, in vivo derived ova, in vitro produced embryos or micromanipulated embryos.

Donor identity shall correspond to the official identification of the animal.

Date of collection shall be indicated for in vivo derived embryos and in the following format: dd.mm.yyyy.

Date of freezing shall be indicated in the following format: dd.mm.yyyy.

Approval number of the team: shall correspond to the approved embryo collection team or embryo production team by which the ova/embryos were collected/produced, processed and stored; and listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm

Part II:

(1) Delete as appropriate.

(2) Only third countries or parts thereof listed in Annex I to Decision 2010/472/EU.

(3) Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.

(4) Only for the territory appearing with the entry “V” in column 6 of Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010).

(5) See remarks for exporting country or part thereof concerned in Annex III to Decision 2010/472/EU.

(6) Standards for EHD virus diagnostic tests are described in Chapter 2.1.3 of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.

(7) Additional guarantees as laid down in Article 2 of Regulation (EC) No 546/2006 (OJ L 94, 1.4.2006, p. 28).

(8) Only approved semen collection centres listed in accordance with Article 11(4) and Article 17(3)(b) of Directive 92/65/EEC on the Commission websites:

http://ec.europa.eu/food/animal/approved_establishments/establishments_vet_field_en.htm;

http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm

(9) Does not apply to ova.

Official veterinarian (*)

Name (in capital letters):

Qualification and title:

Date:

Signature:

Stamp:

(*) The signature and the stamp must be in a different colour to that of the printing.’

---

(*1)  Certificates in accordance with the Agreement between the European Community and the Swiss Confederation on Trade in Agricultural Products as approved by Decision 2002/309/EC, Euratom of the Council, and of the Commission as regards the Agreement on Scientific and Technological Cooperation of 4 April 2002 on the conclusion of seven Agreements with the Swiss Federation (OJ L 114, 30.4.2002, p. 1).’

*1

(*2)  Certificates in accordance with the Agreement between the European Community and the Swiss Confederation on Trade in Agricultural Products as approved by Decision 2002/309/EC.’

*2

---